The effect of exercise training on beta-adrenergic stimulation of fat metabolism in obese men

Int J Obes Relat Metab Disord. 2001 Jan;25(1):16-23. doi: 10.1038/sj.ijo.0801470.

Abstract

Objective: To investigate the in vivo effect of exercise training at high and low intensity on beta-adrenergic stimulated fat metabolism in obese men at rest.

Method: Twenty-three obese, healthy subjects were randomly divided in a low-intensity exercise training program (40% VO(2max), n=7), a high-intensity exercise training program (70% VO(2max); n=8), or a non-exercising control group (n=8). The exercise training program lasted for 12 weeks with a training frequency of 3 times per week. Before and after the intervention body composition and maximal aerobic capacity were measured as well as fat metabolism at rest and during beta-adrenergic stimulation by isoprenaline. For comparison, six lean subjects served as a control group. They participated in a low-intensity exercise training program and underwent the same measurements as the obese subjects.

Results: Relative fat oxidation decreased significantly during infusion of an increasing dose of isoprenaline in the obese low-intensity and high-intensity exercise training groups as well as in the lean group (P<0.01). Exercise training failed to influence the effect of beta-adrenergic stimulation on relative fat oxidation in obese men at both intensities and in lean men. In addition, beta-adrenergic-mediated lipolysis did not seem to be different after low intensity exercise training in lean and obese men. Lipolysis might be increased after high-intensity exercise training in obese men.

Conclusion: Low- and high-intensity exercise training in obese men failed to affect beta-adrenergic mediated relative fat oxidation in vivo. beta-Adrenergic-mediated lipolysis might be increased in obese men after HI exercise training only. The effect of low-intensity exercise training on beta-adrenergic-mediated fat metabolism was similar in lean and obese men. International Journal of Obesity (2001) 25, 16-23

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology*
  • Adult
  • Body Composition
  • Energy Metabolism
  • Exercise / physiology*
  • Glycerol / blood
  • Humans
  • Isoproterenol / pharmacology*
  • Lipid Metabolism*
  • Lipolysis / drug effects
  • Male
  • Middle Aged
  • Obesity / metabolism
  • Obesity / therapy*
  • Oxidation-Reduction
  • Oxygen Consumption
  • Time Factors

Substances

  • Adrenergic beta-Agonists
  • Isoproterenol
  • Glycerol